Ascend Wellness Holdings AAWH
OTC AAWH
$0.48 +0.02 (+5.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Ascend Wellness Holdings (AAWH) Shares Outstanding (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Shares Outstanding (Entity) of $202.8 million for Q1 2026, down 1.17% year-over-year from $205.2 million in Q1 2025, and little changed quarter-over-quarter from $202.2 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Shares Outstanding (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $202.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) fell 1.17% year-over-year to $202.8 million; the TTM figure through Mar 2026 stood at $202.8 million (down 1.17% YoY), while the FY2025 annual figure was $202.2 million, down 1.37% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $202.8 million, roughly flat from $202.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $214.4 million in Q3 2024, with the low at $174.5 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Entity) is $203.3 million (2025), against an average of $200.4 million.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) jumped 63.9% in 2022, then fell 5.5% in 2025.
  • Ascend Wellness Holdings' Shares Outstanding (Entity) stood at $188.1 million in 2022, then climbed by 10.0% to $206.9 million in 2023, then fell by 0.89% to $205.0 million in 2024, then fell by 1.37% to $202.2 million in 2025, then advanced by 0.3% to $202.8 million in 2026.
  • Business Quant data shows AAWH's Shares Outstanding (Entity) at $202.8 million in Q1 2026, $202.2 million in Q4 2025, and $202.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 1.17 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 832.44 Mn
10 Ascend Wellness Holdings 97.42 Mn 30.42 Mn 45.49 Mn 203.01 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 202.45 Mn
Mar 31, 2026 202.45 Mn
Dec 31, 2025 203.48 Mn
Sep 30, 2025 202.97 Mn
Jun 30, 2025 203.87 Mn
Mar 31, 2025 205.00 Mn
Dec 31, 2024 212.43 Mn
Sep 30, 2024 214.29 Mn
Jun 30, 2024 213.16 Mn
Mar 31, 2024 208.95 Mn
Dec 31, 2023 199.15 Mn
Sep 30, 2023 205.71 Mn
Jun 30, 2023 195.65 Mn
Mar 31, 2023 188.49 Mn
Dec 31, 2022 183.38 Mn
Sep 30, 2022 187.70 Mn
Jun 30, 2022 185.31 Mn
Mar 31, 2022 172.49 Mn
Dec 31, 2021 149.43 Mn
Sep 30, 2021 169.88 Mn